Taurine added to standard treatment for multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This trial tests whether adding taurine – a natural amino acid – to your usual MS medication can help manage symptoms and slow the disease. If you are already on a stable MS treatment, this extra supplement might offer additional benefits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a diagnosis of multiple sclerosis (MS) based on standard criteria.
- You are on a stable disease-modifying therapy (a medication to control MS) before joining.
- Your EDSS score – a measure of disability – is between 1.0 and 5.5.
- You are willing to follow study procedures and attend follow-up visits.
- You are not pregnant or breastfeeding, and agree to use effective birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether taking taurine affects blood sugar control, cholesterol/fats, and inflammation in people with type 2 diabetes. It may help by improving these lab markers, which are linked to long-term health risks.
This study tests whether adding a probiotic supplement to your usual MS treatment (or to no treatment) can help manage relapsing-remitting multiple sclerosis. It aims to see if the probiotic is safe and beneficial as an add-on therapy.
This trial tests if taking taurine, a natural amino acid supplement, can help reduce lingering symptoms of COVID-19 that last for months. If you have had COVID-19 and still have symptoms like fatigue or brain fog for at least 2 months after 3 months from your infection, this study might be for you.
This study tests whether N-acetyl cysteine (a supplement-like medicine) changes body and brain function in people with multiple sclerosis. It may help researchers understand how it affects brain chemistry and activity using special brain imaging.
This study tests whether terfenadine, an allergy medicine, is safe and helpful for people with relapsing-remitting multiple sclerosis (MS). It may reduce MS activity and improve outcomes.
This trial tests a gentle brain stimulation technique called transcranial direct current stimulation (tDCS) to see if it helps improve symptoms in people with multiple sclerosis (MS). It may offer a non-drug option to manage symptoms like fatigue, walking difficulties, or other issues.
Hear when a new Multiple Sclerosis (MS) - Relapsing-remitting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.